Sander van Leeuwen

Dr. Sander van Leeuwen

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Biotechnology
Verified
Journal Article
Closed access
HLHans Leemhuis
Hans Leemhuis
TPTjaard Pijning
Tjaard Pijning
JDJustyna M. Dobruchowska
Justyna M. Dobruchowska
SLSander van Leeuwen
Sander van Leeuwen
SKSlavko Kralj
Slavko Kralj
LDLubbert Dijkhuizen
Lubbert Dijkhuizen

3 November 2020 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Open access
SLSander van Leeuwen
Sander van Leeuwen
EPEvelien M. Te Poele
Evelien M. Te Poele
ACAnastasia Chrysovalantou Chatziioannou
Anastasia Chrysovalantou Chatziioannou
EBEric Benjamins
Eric Benjamins
AHAlfred Haandrikman
Alfred Haandrikman
LDLubbert Dijkhuizen
Lubbert Dijkhuizen
Human milk is considered the golden standard in infant nutrition. Free oligosaccharides in human milk provide important health benefits. These oligosaccharides function as prebiotics, immune modulators, and pathogen inhibitors and were found to improve barrier function in the gut. Infant formulas nowadays often contain prebiotics but lack the specific functions of human milk oligosaccharides (hMOS). Milk from domesticated animals also contains milk oligosaccharides but at much lower levels and with less diversity. Goat milk contains significantly more oligosaccharides (gMOS) than bovine (bMOS) or sheep (sMOS) milk and also has a larger diversity of structures. This review summarizes structural studies, revealing a diversity of up to 77 annotated gMOS structures with almost 40 structures fully characterized. Quantitative studies of goat milk oligosaccharides range from 60 to 350 mg/L in mature milk and from 200 to 650 mg/L in colostrum. These levels are clearly lower than in human milk (5–20 g/L) but higher than in other domesticated dairy animals, e.g., bovine (30–60 mg/L) and sheep (20–40 mg/L). Finally, the review focuses on demonstrated and potential functionalities of gMOS. Some studies have shown anti-inflammatory effects of mixtures enriched in gMOS. Goat MOS also display prebiotic potential, particularly in stimulating growth of bifidobacteria preferentially. Although functional studies of gMOS are still limited, several structures are also found in human milk and have known functions as immune modulators and pathogen inhibitors. In conclusion, goat milk constitutes a promising alternative source for milk oligosaccharides, which can be used in infant formula.

7 May 2016 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
XMXiangfeng Meng
Xiangfeng Meng
JGJoana Gangoiti
Joana Gangoiti
YBYuxiang Bai
Yuxiang Bai
TPTjaard Pijning
Tjaard Pijning
SLSander van Leeuwen
Sander van Leeuwen
LDLubbert Dijkhuizen
Lubbert Dijkhuizen
Lactic acid bacteria (LAB) are known to produce large amounts of α-glucan exopolysaccharides. Family GH70 glucansucrase (GS) enzymes catalyze the synthesis of these α-glucans from sucrose. The elucidation of the crystal structures of representative GS enzymes has advanced our understanding of their reaction mechanism, especially structural features determining their linkage specificity. In addition, with the increase of genome sequencing, more and more GS enzymes are identified and characterized. Together, such knowledge may promote the synthesis of α-glucans with desired structures and properties from sucrose. In the meantime, two new GH70 subfamilies (GTFB- and GTFC-like) have been identified as 4,6-α-glucanotransferases (4,6-α-GTs) that represent novel evolutionary intermediates between the family GH13 and “classical GH70 enzymes”. These enzymes are not active on sucrose; instead, they use (α1 → 4) glucans (i.e. malto-oligosaccharides and starch) as substrates to synthesize novel α-glucans by introducing linear chains of (α1 → 6) linkages. All these GH70 enzymes are very interesting biocatalysts and hold strong potential for applications in the food, medicine and cosmetic industries. In this review, we summarize the microbiological distribution and the structure–function relationships of family GH70 enzymes, introduce the two newly identified GH70 subfamilies, and discuss evolutionary relationships between family GH70 and GH13 enzymes.

1 May 2008 in Carbohydrate Research
Verified
Journal Article
Closed access
SLSander van Leeuwen
Sander van Leeuwen
BLBas R. Leeflang
Bas R. Leeflang
GGGerrit J. Gerwig
Gerrit J. Gerwig
JKJohannis P. Kamerling
Johannis P. Kamerling

15 November 2011 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
SKSlavko Kralj
Slavko Kralj
PGPieter Grijpstra
Pieter Grijpstra
SLSander van Leeuwen
Sander van Leeuwen
HLHans Leemhuis
Hans Leemhuis
JDJustyna M. Dobruchowska
Justyna M. Dobruchowska
LDLubbert Dijkhuizen
Lubbert Dijkhuizen
Lactobacillus reuteri 121 uses the glucosyltransferase A (GTFA) enzyme to convert sucrose into large amounts of the α- d -glucan reuteran, an exopolysaccharide. Upstream of gtfA lies another putative glucansucrase gene, designated gtfB . Previously, we have shown that the purified recombinant GTFB protein/enzyme is inactive with sucrose. Various homologs of gtfB are present in other Lactobacillus strains, including the L. reuteri type strain, DSM 20016, the genome sequence of which is available. Here we report that GTFB is a novel α-glucanotransferase enzyme with disproportionating (cleaving α1→4 and synthesizing α1→6 and α1→4 glycosidic linkages) and α1→6 polymerizing types of activity on maltotetraose and larger maltooligosaccharide substrates (in short, it is a 4,6-α-glucanotransferase). Characterization of the types of compounds synthesized from maltoheptaose by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS), methylation analysis, and 1-dimensional 1 H nuclear magnetic resonance (NMR) spectroscopy revealed that only linear products were made and that with increasing degrees of polymerization (DP), more α1→6 glycosidic linkages were introduced into the final products, ranging from 18% in the incubation mixture to 33% in an enriched fraction. In view of its primary structure, GTFB clearly is a member of the glycoside hydrolase 70 (GH70) family, comprising enzymes with a permuted (β/α) 8 barrel that use sucrose to synthesize α- d -glucan polymers. The GTFB enzyme reaction and product specificities, however, are novel for the GH70 family, resembling those of the GH13 α-amylase type of enzymes in using maltooligosaccharides as substrates but differing in introducing a series of α1→6 glycosidic linkages into linear oligosaccharide products. We conclude that GTFB represents a novel evolutionary intermediate between the GH13 and GH70 enzyme families, and we speculate about its origin.

24 April 2019 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
KBKlaudyna Borewicz
Klaudyna Borewicz
FGFangjie Gu
Fangjie Gu
Edoardo SaccentiEdoardo Saccenti
Edoardo Saccenti
IAIlja C.W. Arts
Ilja C.W. Arts
JPJohn Penders
John Penders
Hauke SmidtHauke Smidt
Hauke Smidt
Scope: Understanding the biological functions of human milk oligosaccharides (HMOs) in shaping gastrointestinal (GI) tract microbiota during infancy is of great interest. A link between HMOs in maternal milk and infant fecal microbiota composition is examined and the role of microbiota in degrading HMOs within the GI tract of healthy, breastfed, 1‐month‐old infants is investigated.Methods and results: Maternal breast milk and infant feces are from the KOALA Birth Cohort. HMOs are quantified in milk and infant fecal samples using liquid chromatography‐mass spectrometry. Fecal microbiota composition is characterized using Illumina HiSeq 16S rRNA gene amplicon sequencing. The composition is associated with gender, delivery mode, and milk HMOs: Lacto‐N‐fucopentaose I and 2′‐fucosyllactose. Overall, Bifidobacterium, Bacteroides, Escherichia–Shigella, and Parabacteroides are predominating genera. Three different patterns in infant fecal microbiota structure are detected. GI degradation of HMOs is strongly associated with fecal microbiota composition, and there is a link between utilization of specific HMOs and relative abundance of various phylotypes (operational taxonomic units).Conclusions: HMOs in maternal milk are among the important factors shaping GI tract microbiota in 1‐month‐old breastfed infants. An infant's ability to metabolize different HMOs strongly correlates with fecal microbiota composition and specifically with phylotypes within genera Bifidobacterium, Bacteroides, and Lactobacillus.